Center for Biologics Evaluation and Research

Center for Biologics Evaluation and Research

The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

61%


Total
Publications

4.3K


Total Open
Publications

2.7K


Total
Citations

191K


Open Access
Percentage

61%


Total
Publications

4.3K


Total Open
Publications

2.7K


Total
Citations

191K

Wikipedia

Website

download

Breakdown

14% 34% 14% 38%

Publisher Open

14%

Both

34%

Other Platform Open

14%

Closed

38%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220240Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

750

Hybrid 22%

446

No Guarantees 42%

873

Other Platform Open

Domain 92%

1.9K

Public 13%

268

Institution 13%

263

Other Internet 6%

118

Preprint 5%

113

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
1.9K
Europe PMC
Domain
1.5K
Semantic Scholar
Public
234
bioRxiv
Preprint
75
DOI
Other Internet
51
Figshare
Public
44
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
38
CiteSeer X
Other Internet
35
medRxiv
Preprint
20
Zenodo
Public
18
1 / 16

Data updated 3 October 2023

Share

Share

Share